Exact Mass: 667.4060271999999

Exact Mass Matches: 667.4060271999999

Found 31 metabolites which its exact mass value is equals to given mass value 667.4060271999999, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Gluten exorphin C

[(2S)-1-{[(1,1-dihydroxy-4-methylpentan-2-yl)amino]oxy}-3-hydroxy-1-oxopropan-2-yl]amino (2S,3S)-2-[({1-[2-amino-1-hydroxy-3-(4-hydroxycyclohexyl)propoxy]pyrrolidin-2-yl}(hydroxy)methoxy)amino]-3-methylpentanoate

C29H57N5O12 (667.4004)


Gluten exorphin B5 is a pentapeptide with the sequence Tyr-Pro-Ile-Ser-Leu. Gluten exorphins are a group of opioid peptides which are formed during digestion of the gluten protein. It has been hypothesized that people with autism and schizophrenia have abnormal leakage from the gut of these compounds, which then pass into the brain and disrupt brain function. This is partly the basis for the gluten-free, casein-free diet. The scientific evidence for this diet and its effects is still disputed.

   

DG(10:0/LTE4/0:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-{[(2S)-1-(decanoyloxy)-3-hydroxypropan-2-yl]oxy}-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C36H61NO8S (667.4118)


DG(10:0/LTE4/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/LTE4/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(LTE4/10:0/0:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2S)-2-(decanoyloxy)-3-hydroxypropoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C36H61NO8S (667.4118)


DG(LTE4/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(LTE4/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/LTE4)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2R)-3-(decanoyloxy)-2-hydroxypropoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C36H61NO8S (667.4118)


DG(10:0/0:0/LTE4) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(LTE4/0:0/10:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2S)-3-(decanoyloxy)-2-hydroxypropoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

C36H61NO8S (667.4118)


DG(LTE4/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/LTE4/0:0)

DG(10:0/LTE4/0:0)

C36H61NO8S (667.4118)


   

DG(LTE4/10:0/0:0)

DG(LTE4/10:0/0:0)

C36H61NO8S (667.4118)


   

DG(10:0/0:0/LTE4)

DG(10:0/0:0/LTE4)

C36H61NO8S (667.4118)


   

DG(LTE4/0:0/10:0)

DG(LTE4/0:0/10:0)

C36H61NO8S (667.4118)


   
   

SHexCer 14:1;2O/12:0

SHexCer 14:1;2O/12:0

C32H61NO11S (667.3965)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadecan-2-yl]propanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadecan-2-yl]propanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadecan-2-yl]butanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadecan-2-yl]butanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridecan-2-yl]heptanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridecan-2-yl]heptanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradecan-2-yl]hexanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradecan-2-yl]hexanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadecan-2-yl]acetamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadecan-2-yl]acetamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadecan-2-yl]pentanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadecan-2-yl]pentanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodecan-2-yl]octanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodecan-2-yl]octanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundecan-2-yl]nonanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundecan-2-yl]nonanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]dodecanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]dodecanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydecan-2-yl]decanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydecan-2-yl]decanamide

C32H61NO13 (667.4143)


   

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonan-2-yl]undecanamide

N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonan-2-yl]undecanamide

C32H61NO13 (667.4143)


   
   

PS O-18:0/8:1;O2

PS O-18:0/8:1;O2

C32H62NO11P (667.406)


   
   

IPC 14:1;O2/12:0

IPC 14:1;O2/12:0

C32H62NO11P (667.406)


   

IPC 15:1;O2/11:0

IPC 15:1;O2/11:0

C32H62NO11P (667.406)


   

IPC 16:1;O2/10:0

IPC 16:1;O2/10:0

C32H62NO11P (667.406)


   
   

(5z)-n-[(6r,9s,12r,15s,16r)-3-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-9,12-bis(hydroxymethyl)-6-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]dodec-5-enimidic acid

(5z)-n-[(6r,9s,12r,15s,16r)-3-[(2s)-butan-2-yl]-5,8,11,14-tetrahydroxy-9,12-bis(hydroxymethyl)-6-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]dodec-5-enimidic acid

C33H57N5O9 (667.4156)


   

n-[5,8,11,14-tetrahydroxy-9,12-bis(hydroxymethyl)-6-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]dodec-5-enimidic acid

n-[5,8,11,14-tetrahydroxy-9,12-bis(hydroxymethyl)-6-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]dodec-5-enimidic acid

C33H57N5O9 (667.4156)